We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.32B
AUM Growth
-$11.8M
Cap. Flow
-$170M
Cap. Flow %
-5.1%
Top 10 Hldgs %
11.89%
Holding
1,567
New
166
Increased
531
Reduced
576
Closed
161

Sector Composition

Rank Sector Weight
1 Energy 12.89%
2 Healthcare 10.81%
3 Industrials 9.51%
4 Technology 9.45%
5 Financials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COV
276
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$2.82M 0.08%
31,263
-30,471
-49% -$2.28M
B
277
Barrick Mining
B
$62.2B
$2.81M 0.08%
153,754
-46,010
-23% -$797K
DVA icon
278
DaVita
DVA
$15.1B
$2.8M 0.08%
38,707
+4,400
+13% +$306K
FTA icon
279
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.38B
$2.79M 0.08%
64,138
+16,043
+33% +$676K
EXPD icon
280
Expeditors International
EXPD
$22.9B
$2.79M 0.08%
63,110
-283
-0.4% -$12.2K
CBI
281
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.78M 0.08%
40,802
-21,387
-34% -$1.7M
VEA icon
282
Vanguard FTSE Developed Markets ETF
VEA
$226B
$2.77M 0.08%
65,103
+2,624
+4% +$111K
MPV
283
Barings Participation Investors
MPV
$168M
$2.77M 0.08%
202,493
+10,624
+6% +$141K
TIP icon
284
iShares TIPS Bond ETF
TIP
$14.5B
$2.76M 0.08%
23,946
+9,726
+68% +$1.11M
REGN icon
285
Regeneron Pharmaceuticals
REGN
$68.8B
$2.76M 0.08%
9,767
+298
+3% +$88.3K
HCA icon
286
HCA Healthcare
HCA
$84.8B
$2.75M 0.08%
48,862
-2,994
-6% -$158K
DOC icon
287
Healthpeak Properties
DOC
$15.4B
$2.73M 0.08%
72,562
+675
+0.9% +$25.4K
PH icon
288
Parker-Hannifin
PH
$125B
$2.71M 0.08%
21,562
+800
+4% +$99.7K
KS
289
DELISTED
KapStone Paper and Pack Corp.
KS
$2.69M 0.08%
81,291
+73,245
+910% +$2.08M
RCI icon
290
Rogers Communications
RCI
$17.7B
$2.68M 0.08%
66,645
+5,465
+9% +$221K
SDLP
291
DELISTED
SEADRILL PARTNERS LLC
SDLP
$2.68M 0.08%
8,086
-821
-9% -$256K
WBD icon
292
Warner Bros
WBD
$64.6B
$2.68M 0.08%
70,515
+484
+0.7% +$19K
AZO icon
293
AutoZone
AZO
$48.3B
$2.67M 0.08%
4,983
-37
-0.7% -$19.6K
GSK icon
294
GSK
GSK
$103B
$2.66M 0.08%
39,734
-3,663
-8% -$248K
VGK icon
295
Vanguard FTSE Europe ETF
VGK
$30B
$2.63M 0.08%
43,917
-1,358
-3% -$81.8K
GNRC icon
296
Generac Holdings
GNRC
$11.9B
$2.63M 0.08%
53,902
-3,227
-6% -$170K
ES icon
297
Eversource Energy
ES
$28.2B
$2.63M 0.08%
55,530
-5,777
-9% -$265K
EMR icon
298
Emerson Electric
EMR
$82.9B
$2.62M 0.08%
39,469
-1,588
-4% -$107K
CMS icon
299
CMS Energy
CMS
$23.1B
$2.61M 0.08%
83,654
-3,600
-4% -$107K
MITT
300
TPG Mortgage Investment Trust
MITT
$230M
$2.59M 0.08%
45,580
+17
+0% +$937

Similar funds

Oppenheimer & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Oppenheimer & Co held 1,567 positions worth $3.32B, down 0.35% from $3.34B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co withdrew a net $170M in Q2 2014, closing 161 positions and reducing 576 holdings. Its most notable exit was O'Reilly Automotive, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Energy at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oppenheimer & Co opened a new position in FOREST LABORATORIES INC worth $5.98M.

  • Oppenheimer & Co's largest Q2 2014 buy was FOREST LABORATORIES INC: 60,413 shares worth $5.98M.
  • Oppenheimer & Co added most to Kinder Morgan in Q2 2014, an estimated $5.36M increase.
  • Oppenheimer & Co's biggest Q2 2014 reduction was Monsanto Co, cutting an estimated $31.6M.
  • Oppenheimer & Co fully exited O'Reilly Automotive in Q2 2014, selling an estimated $9.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.32B portfolio in Q2 2014.
  • Oppenheimer & Co opened 166 new positions and closed 161 in Q2 2014.
  • Oppenheimer & Co's portfolio value fell 0.35% quarter-over-quarter to $3.32B.

Based on Oppenheimer & Co's 13F filing for Q2 2014, filed 14 Aug 2014.